Axovant Sciences Ltd (N:AXON)

Business Focus: Bio Therapeutic Drugs

Recent Price for AXON
USD 23.090 N/A (N/A)
NYSE Delayed 15 minutes
Apr 25 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.000 N/A N/A 2,445.32
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.000 0.0% 1,068,322  

Latest 10 SEC filings (by transaction date) for AXON within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Apr 19/17 Apr 17/17 Vernon W Anthony Direct Ownership Common Shares P - Open market or private purchase 53,937 $18.54
Apr 19/17 Apr 17/17 Falberg Kathryn E Direct Ownership Common Shares P - Open market or private purchase 53,937 $18.54
Apr 19/17 Apr 17/17 Hung David Direct Ownership Common Shares P - Open market or private purchase 539,375 $18.54
Apr 11/17 Apr 11/17 Falberg Kathryn E Direct Ownership Common Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 11/17 Apr 11/17 Vernon W Anthony Direct Ownership Common Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 11/17 Apr 11/17 McCourt Marion Direct Ownership Common Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 11/17 Apr 11/17 Hung David Direct Ownership Common Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 11/17 Apr 7/17 McCourt Marion Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 465,000  
Apr 11/17 Apr 7/17 Hung David Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 2,000,000  
Apr 11/17 Apr 7/17 Hung David Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 2,000,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for AXON within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Apr 19/17 Apr 17/17 Vernon W Anthony Direct Ownership Common Shares P - Open market or private purchase 53,937 $18.54
Apr 19/17 Apr 17/17 Falberg Kathryn E Direct Ownership Common Shares P - Open market or private purchase 53,937 $18.54
Apr 19/17 Apr 17/17 Hung David Direct Ownership Common Shares P - Open market or private purchase 539,375 $18.54
Apr 11/17 Apr 7/17 McCourt Marion Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 465,000  
Apr 11/17 Apr 7/17 Hung David Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 2,000,000  
Apr 11/17 Apr 7/17 Hung David Direct Ownership Employee Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 2,000,000  
Apr 11/17 Apr 11/17 Falberg Kathryn E Direct Ownership Common Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 11/17 Apr 11/17 Vernon W Anthony Direct Ownership Common Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 11/17 Apr 11/17 McCourt Marion Direct Ownership Common Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 11/17 Apr 11/17 Hung David Direct Ownership Common Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $AXON

StockTwits